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On 15-16 September 1997, the U.S. Environmental Protection Agency sponsored the Conference
on Preventable Causes of Cancer in Children. The conference was convened to examine rising
trends in reported incidence of childhood cancer and the association of these trends with
environmental exposures. This paper summarizes recommendations for future research offered by
participants. These recommendations included more collaborative research integrating
epidemiology, molecular biology, toxicology, and risk assessment; the development of better
protocols for toxicologic testing including carcinogenicity using young animals; and research
focused on specific periods of development during which susceptibility to environmental agents
may be enhanced. Also recommended was enhanced use and development of molecular
biomarkers for identification of susceptible populations, and documentation of exposures and
effects in epidemiologic and toxicologic studies. Although toxicologic testing is considered essential
to determine the effects of potential carcinogens on biological organisms, participants emphasized
the need to link these findings with epidemiologic and exposure assessment research. Environ
Health Perspect 106(Suppl 3):867-873 (1998). http.//ehpnetl.niehs.nih.gov/docs/1998/Suppl-3/
867-873carroquino/abstract.html
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Introduction
Each year in the United States, about 8000 medical advances have resulted in dramatic
new cases of cancer are reported among reductions in the death rate from child-
children under 15 years ofage. Although hood cancer, the occurrence ofnew cancer
childhood cancer is a rare disease and cases among children has continued to rise
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during the last two decades. Reported
incidence rates for all cancer sites com-
bined in children have risen by about
10% in the 1974 to 1991 compiling
period (1), representing an average rate
increase of about 1% (95% confidence
interval, 0.6-1.3) per year (2). The
reported incidence of gliomas and acute
lymphocyte leukemia, the two most com-
mon forms of cancer, rose by about 40
(3) and 5% (4), respectively, for children
in the under-15 age group. For a number
of cancers (astroglial tumors, retinoblas-
tomas, neuroblastomas, rhabdomyosarco-
mas, and acute lymphocytic leukemia),
the reported increases in incidence
appeared strongest for young children,
especially those in the first through third
years oflife (2). For other types ofcancer,
for which the number of cases is small,
such as Wilms tumors and non-Hodgkin
lymphoma, the trends in incidence are
difficult to quantify. Wilms tumor
increased by about 46% (3) for the same
age group, and bone and joint cancers
were up by about 16% in the 0 to 19 age
group (3). The causes of these reported
increases in childhood cancer incidence
have not been identified.
Most cancer results from the interaction
between genetic factors and the environ-
ment (5,6). In this context, environment is
defined broadly and includes diet, alcohol,
drugs, tobacco, and all other nongenetic
factors as well as classic environmental tox-
ins. It has been estimated that about 80 to
90% ofall cancers are attributable to envi-
ronmental factors acting in conjunction
with both genetic and acquired susceptibil-
ity (7); in infants and children the fraction
ofcancers due to environmental factors is
probably somewhat lower than in adults.
Most research efforts in recent years have
been dedicated to the study ofmechanisms
of action of chemical carcinogens (8). A
major challenge of environmental cancer
prevention is to document environment
susceptibility interactions and then to
translate this knowledge into public health
interventions (7).
In September 1997 as a consequence of
the Clinton administration's commitment
to reduce environmental health and safety
risks to children, the U.S. Environmental
Protection Agency (U.S. EPA) convened
the Conference on Preventable Causes of
Childhood Cancer. Leading cancer and
environmental research experts along with
members of the public discussed what is
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known about preventable causes ofcancer
and worked together to formulate a blue-
print for childhood cancer research for the
next decade.
Participants worked in groups that
made recommendations for research in
four areas: a) susceptibility factors, b) epi-
demiologic and risk factors, c) biologic
markers of exposure and effects, and
d) quantitative measurements ofexposure.
This report summarizes the recom-
mendations of the conference and pre-
sents the arguments supporting these
recommendations.
Establish a National
Childhood Cancer Registry
The strongest and virtually unanimous
recommendation from conference partici-
pants was that a national childhood cancer
registry be established.
A national children's cancer registry
would serve as the nation's largest available
data resource for quantification and evalua-
tion ofchild-specific risks ofcancer. The
registry would a) collect and maintain
detailed exposure information on all chil-
dren in the United States who are diag-
nosed with cancer; b) support broader
epidemiologic investigations ofchildren's
cancer than are currently possible; and c)
communicate findings and timely updates
to families, communities, investigators, and
agencies. Registry data could be combined
with other data and incorporated into
maps to show geographic distribution of
cases and generate hypotheses. Data from
the National Health and Nutrition
Examination Survey (NHANES) and from
the U.S. Department ofAgriculture might
be employed as a source ofpopulation-
based referent exposure markers. In addi-
tion, combined use oftheAgency for Toxic
Substances and Disease Registry's haz-
ardous waste site location data and child-
hood cancer occurrence data could point to
valuable research hypotheses.
Efficiency of case identification by the
registry would be improved by collabora-
tion with existing state tumor registries,
Native-American health committees, dini-
cal oncology treatment study groups
(Children's Cancer Group, Pediatric
Oncology Group), and collaboration with
affected communities and families.
An active communications program
would be required to provide families of
participating children with timely reports
of peer-reviewed research findings and
any other information of clinical or
personal significance.
Evaluate Children's Special
Susceptibilities to Cancer
To identify and characterize the preventable
causes ofchildhood cancer, research pro-
grams are required that evaluate the role of
physiological, biochemical, and developmen-
tal factors in children's susceptibility to
cancer. Children may be at disproportionate
risk ofdeveloping cancer because oftheir
increased absorption and retention ofenvi-
ronmental agents, reduced detoxification
and repair during the early stages ofdevelop-
ment, their higher rate ofcell proliferation,
and the fact that cancers initiated in the
womb and in the early years have the oppor-
tunity to develop over many decades (7). In
addition, children may be at greater risk by
virtue oftheir nutritional and health status.
The following recommendations were made:
a) Develop animal models to assess toxi-
cologic differences between children and
adults and to evaluate toxicity to developing
organ systems.
New toxicologic protocols and models
using young animals to predict childhood
risk of cancer are needed. The use ofyoung
animals to predict effects on children
requires additional validation. For exam-
ple, rodents are less mature at birth than
humans. Thus, more pronounced age-
related differences would be anticipated in
rodents than in humans during the neona-
tal period. Rodents and most other com-
monly used test animals mature very
rapidly during this time, so that differences
of even a few days in age can profoundly
affect susceptibility to the toxicity of xeno-
biotic compounds (9). Thus, studies need
to be conducted to determine the parallels
and differences in development between
test animals and humans.
b) Conductresearch to studydevelopmen-
talchanges in metabolism, immunefunction,
andproliferative activity, and how these
changes mayaffectsusceptibility to cancer.
Chemical carcinogenesis is a multistep
process involving genetic and epigenetic
changes in susceptible cells that gain a
selective growth advantage and undergo
clonal expansion as the result ofactivation
of protooncogenes and/or inactivation of
tumor-suppressor genes (10). The occur-
rence ofthese events is modulated by sev-
eral factors that themselves change in the
course ofdevelopment. Thus, DNA dam-
age may be repaired by the action ofDNA
repair enzymes, whose presence and activ-
ity may change with age. Similarly, changes
in metabolism will determine whether
carcinogenic metabolites are formed, thus
allowing for the initiation of the cancer
process. The higher rate ofcell prolifera-
tion of certain tissue during development
may also contribute to the development
ofcancer.
c) Study changes in carcinogen-metabo-
lizingcapacity duringdevelopment,fromges-
tation throughadulthood, to evaluate the role
ofmetabolism in prenatal andpostnatal
susceptibility to carcinogens.
The susceptibility ofchildren to cancer
can be influenced by the presence and
activity of metabolizing enzymes. The
absence of or lower activity of enzymes
that are required to metabolize carcino-
gens to their active form can reduce a
child's risk of cancer following exposure.
By contrast, decreased enzymes that detox-
ify carcinogens can increase cancer risk.
Many enzyme systems change greatly in
activity during early development, and a
number ofmetabolic pathways responsible
for bioactivation or detoxification are not
present in the fetus or are less developed in
the infant. For example, glucouronic acid
conjugation is significantly depressed at
birth, although a well-developed capability
for sulfate conjugation exists (11). Studies
are needed to determine which specific
enzymes lead to changes in susceptibility in
children to carcinogens and which ofthese
enzymes are good predictors ofchildren's
susceptibility to cancer. The presence and
activity ofcarcinogen-metabolizing enzymes
during development from conception
through adulthood should be studied.
d) Study the variability in carcinogen-
metabolizing enzymes in childhoodpopula-
tionsandthe roleofgeneticpolymorphisms in
children ssusceptibility to cancer.
There is great interindividual variability
in the amounts and types ofmetabolizing
enzymes, some ofwhich are under direct
genetic control (12-14). For example,
CYPlAI, whose product metabolizes poly-
cyclic aromatic hydrocarbons (PAH) such as
benzo[a]pyrene is a polymorphic enzyme.
About 10% ofthe Caucasian population has
a highly inducible form ofthe enzyme that
is associated with increased lung cancer in
smokers (7). PAH-DNA adducts are also
elevated in umbilical cord blood and pla-
centa ofnewborns, with the CYPlAl MSP1
polymorphisms, which suggests that the
genetic polymorphism may increase risk
from transplacental PAH exposure (15).
Greater understanding ofinterindividual
variations is key to understanding childhood
susceptibility to cancer.
e) Study the role ofgestational and
preconception exposures that may result in
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increased exposure and/or susceptibility ofthe
fetus to carcinogens.
More information is needed on the
ability of certain carcinogenic compounds
and/or their metabolites to cross the pla-
centa. In addition, little information is
available on the metabolic changes that
occur during pregnancy and how they can
affect the accumulation ofcarcinogens in
the mother or the production ofcarcino-
genic metabolites that could be transferred
to the fetus. The metabolic capacity ofthe
placenta also needs to be evaluated, as it
can result in exposure ofthe fetus to toxic
metabolites. Metabolizing enzymes can be
induced by exposure to structurally related
chemicals (16), dietary factors (12-14),
and disease states (17,18). Furthermore,
maternal exposure to environmental car-
cinogens can result in enzyme induction to
the fetus (12-14).
f) Evaluate the contribution ofcellpro-
liferation to different types ofchildhood
cancer, paying special attention to specific
periods oforgan and tissue development dur-
ing which accelerated cellproliferation may
increasesusceptibility to cancer.
Cell proliferation can contribute to an
increased likelihood ofcarcinogenesis. For
example, PAHs and aflatoxin B1 (AFB1)
produce liver tumors when administered to
newborn rodents but not when adminis-
tered to older animals, presumably because
the liver proliferates rapidly in the develop-
ing system but more slowly in older ani-
mals (19). Women who were in their teens
at the time ofthe atomic bombings had the
greatest risk ofradiation-induced breast
cancer (20). Because cells proliferate faster
in children's bodies than in adults, cell pro-
liferation may be a significant risk factor in
childhood cancer. Some organs, such as the
brain, are fully developed in early child-
hood, whereas others such as the skeletal
system do not achieve maturity until ado-
lescence (19). This may be the reason why
osteosarcoma, the most common bone
cancer, peaks in late adolekcence, a period
ofrapid bone growth (21). More informa-
tion is needed on the growth and matura-
tion ofdifferent organs duringdevelopment,
so that the role of cell proliferation in
childhood cancer can be evaluated.
g) Study the differences in DNA repair
mechanisms between children andadults.
DNA repair mechanisms play an
important role in cancer protection. For
example, the p53 encodes a protein that
modulates DNA repair and cell division
and mutations of the p53 genes are
involved in at least 50% ofall cancers (22).
p53 mutations have been linked with
tobacco smoking (23-25), and it is possible
thatp53mutations occur in the offspring of
smoking mothers. More information is
needed about the differences in DNA repair
mechanisms between children and adults
and the susceptibilities ofgenes such asp53
in children to deleterious mutations.
h) Study theeffects ofcarcinogens on the
developing immune system, from conception
topuberty. Evaluate theprotective role of
the mother's immune system in modulating
prenatalandinfantresponse to carcinogens.
Better information is needed on the
effectiveness of the fetal and childhood
immune system in modulating cancer
response. The extent ofmaternal monitor-
ing offetal, transformed cells is unknown.
It is also not known whether immune
monitoring systems that detect trans-
formed cells, such as T cells, function in
children as effectively as in adults. Because
infants depend on maternal antibodies that
they receive through the placenta and later
from breast milk for their immunity,
greater understanding is needed on the
protective role of the mother's immune
system in modulating prenatal and infant
response to carcinogens. Chemicals that
affect the immune system, such as halo-
genated aromatic hydrocarbons that bind
to the Ah receptor (26), may modify the
host defense mechanism against infection
and cancer (27). Some participants indi-
cated that a lack ofprevious immunologic
challenge to the child might affect the
immune system's ability to detect cancer-
ous cells. Study of the potential use of
immune stimulators such as BCG4 in
stimulating an immune defense mecha-
nism against cancerwas recommended.
i) Continue researchefforts on thedietary
factors that affect susceptibility to cancer.
Assess whether the diets ofinfants and chil-
drenprovide adequate amounts ofnutrients
that are known to be cancerprotective,
including the evaluation ofthe diet ofchil-
dren in poverty. Conduct epidemiologic
studies to determine the association between
obesity in children andcancer.
Dietary factors such as animal fat
intake and the levels of certain vitamins
and micronutrients have been shown to
influence susceptibility to cancer (19).
Epidemiologic studies have identified mul-
tiple known or potential protective agents
in the diet such as vitamins A, C, and E,
various carotenoids, and selenium (28,29).
Although substantial research has been
dedicated to evaluate the role of diet in
cancer prevention, little information is
available on the role ofchildren's diets in
preventing cancer. Children's nutritional
requirements are different from those of
adults, and the effects ofdiet in childhood
cancer prevention may be different from
what would be expected by extrapolating
from adult data. The protective role of
antioxidant and micronutrient exposure
needs to be investigated in children. Also,
because some population subgroups such
as people in poverty (30) and Hispanics
(31) are more likely to suffer form certain
nutrient deficiencies, children ofthese sub-
groups may be at greater risk ofdeveloping
cancer. Cultural differences in diet may
also contribute to differences in cancer risk
among cultural groups. The use of data
from the National Health and Nutrition
Evaluation Survey is recommended to
conduct such studies.
j) Evaluate the role ofmaternalnutrition
and nutrient supplementation with individ-
ual micronutrients duringpregnancy and
lactation in cancerprevention.
Several studies, including a study
reported in this issue (32) have shown a
reduced risk ofchildhood brain cancer asso-
ciated with maternal vitamin supplementa-
tion during pregnancy (33,34). This
demonstrates the importance ofpursuing
this line ofresearch further. More informa-
tion is needed on the protective role ofother
micronutrients during pregnancy. The role
ofmicronutrient supplementation during
lactation and the first years oflife in cancer
prevention also needs further evaluation. To
evaluate the diet ofpregnantwomen, the use
ofdatafrom NHANES is recommended.
Improve Epidemiologic
Methods and Increase Use
of Epidemiologic Data in
RiskAssessment
Epidemiologic study ofchildhood cancer is
difficult because ofthe rarity ofthe disease
and the broad array of environmental,
viral, and genetic risk factors potentially
involved in pediatric carcinogenesis.
Environmental exposures are usually low,
and associations between environmental
exposures and disease are often weak.
Clustering ofchildhood cancer in commu-
nities has been the impetus for many
studies, but such studies have rarely, if
ever, clearly identified a cause. These clus-
ter analyses have many limitations. They
usually involve a small number ofcases and
a large number ofpotential environmental
factors. Exposures can rarely be quantified
and confounding factors are difficult to
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control. Although cluster analysis has
limitations, the group suggested and space
associations may yield associations between
environmental factors and disease thatwere
previously undetected.
k) Facilitate cooperation amongdifferent
countries to conductlargeepidemiologicstudies.
The infrequent occurrence ofchildhood
cancer and the large numbers ofpotential
factors involved make it difficult to con-
duct studies with acceptable epidemio-
logic power. Low exposure levels and the
difficulty of finding unexposed control
population make it difficult to establish
cause-and-effect relationships. To overcome
these limitations, conference participants
recommended the design oflarge interna-
tional collaborative studies. Such studies
would increase statistical power and allow
for multifactorial analysis. Because the
degree ofchemical exposure varies widely
among countries, international studies
would also allow examination of a large
range ofexposures and disease outcomes.
I) Examine the association between
childhoodcancerincidenceandbirth defects.
Many forms ofchildhood cancer such
as early brain cancer can be thought of as
terminal cell differentiation, a developmen-
tal process that can start prenatally or very
early after birth and culminate in the for-
mation of a tumor in early childhood.
Thus, cancers that are viewed as a type of
terminal differentiation and that appear as
a result ofrisk factors during gestation may
be considered birth defects. A relationship
may exist between birth defects and early
childhood cancer. For example, a negative
correlation exists between the intake of
folate in pregnancy and the occurrence of
neural tube defects and certain malignant
brain tumors in children (35). The distrib-
ution ofchildhood cancers with respect to
birth defects and environmental risk factors
should be examined. Chromosomal alter-
ations in the fetus and newborn should be
evaluated in relation to childhood cancer
and birth defects.
Develop and Validate
Biomarkers for Childhood
Cancer and Increase Use of
Biomarkers in Risk
Assessment
Biomarkers have been used in clinical and
epidemiologic research to document toxic
exposures and to investigate genetic sus-
ceptibility to environmental toxins, but
little environmental research has been per-
formed using biomarkers to identify
affected children. Except with radon,
asbestos, and some pesticide exposures, there
have been very few attempts to develop new
biomarker techniques to identify toxic
exposures in children.
It is recommended that significant
efforts be dedicated to develop new sensi-
tive biomarkers for childhood exposures
and susceptibilities and that these are val-
idated in laboratory and epidemiologic
studies. The use ofbiomarkers in hypoth-
esis-testing studies in conjunction with
exposure assessment, personal monitor-
ing, and validated questionnaires is also
recommended. The following specific
recommendations were made:
a) Studyandvalidatethelinkages between
exposure biomarkers and biomarkers ofeffect
andbetween biomarkers ofeffectandclinical
outcome. Develop intermediate markers
(surrogate markers) that can assist in linking
exposure todisease outcomes.
Research to validate biomarkers includes
determining the relationship between the
biologic parameter measured and both
upstream and downstream events in the
exposure-effects continuum (36-38). For
example, ahemoglobin (Hb) adduct consid-
ered for use as an exposure biomarker for a
xenobiotic should exhibit a predictable rela-
tionship to ambient exposure level (39). By
validating markers in this fashion, it
becomes possible to use biomarkers in risk
assessment to predict specific health effects.
Because ofthe physiologic, metabolic, and
developmental differences between children
and adults, the relationship ofexposure and
effect biomarkers to other events of the
continuum may be different between adults
and children and should be evaluated. For
example, newborns at delivery were found
to have higher levels ofPAH-DNAadducts
in the blood than the mothers, despite the
fact that transplacental exposure to the
PAHs is estimated to be an order ofmagni-
tude or more lower than maternal exposure
(40). More importantly, the relationship
between early effects and appearance ofa
disease may be different from adults. The
potentially shorter latency period for child-
hood cancer in comparison to adult cancer
suggests that the clinical significance of
exposure or early effect biomarkers varies
with age.
b) Develop and validate susceptibility
biomarkers such as thepresence andactivity
ofenzymes involved in carcinogenic bioac-
tivation or detoxification through stages of
development, DNA adducts, and biomark-
ersfor nutritional status. Use susceptibility
biomarkers to determine the range of
susceptibility in thepopulation andidentijf
subpopulations at risk.
Studies of susceptibility biomarkers
such as the presence or absence of meta-
bolic enzymes would provide information
on the differential susceptibility ofchildren
versus adults. Because polymorphisms exist
for many of the enzymes involved in car-
cinogen metabolism, biomarkers for these
polymorphisms could potentially be used
to identify subgroups of infants with
greatest potential risks. Biomarkers for the
presence ofchemically inducible enzymes
may also serve as indicators of multiple
exposures. In addition, other types ofsus-
ceptibility biomarkers such as the levels of
certain nutritional elements can be used
to identify subsets of infants at risk.
Susceptibility biomarkers can potentially
provide information on a wide range of
susceptibility factors related to age, gender,
ethnicity, degree of exposure, and health
and nutritional status.
c) Develop biomarkers that woulddetect
maternalpreconception exposures, transpla-
centalexposures to thefetus, andearly child-
hood exposures, e.g., biomarkersforpassive
smokingduringtheseperiods.
The reported increase in childhood
cancer rates at younger ages suggests that
environmental exposure during gestation
and preconception may be involved.
Experiments with a number ofcarcinogens
(induding PAHs, nitrosamines, and AFB1)
show that the risk ofcancer is heightened if
exposure begins in uteroor in infancy rather
than in adulthood (9,41). Therefore, it is
necessary to emphasize the study of bio-
markers thatwould detect maternal precon-
ception exposures and transplacental
exposures to the fetus. Biomarkers for early
childhood exposures are also needed.
d) Increase the use ofbiomarkers in
qualitative and quantitative aspects ofrisk
assessment.
Biomarkers can be used in several
aspects of risk assessment. Sensitive bio-
markers can be employed to assess early
indicators ofharm in human populations
with suspected environmental exposure
(39). In hazard identification, the use of
sensitive biomarkers can substitute for the
need to use end points located at the
extreme right ofthe exposure-disease con-
tinuum such as disease or tumor formation.
Biomarkers can also provide information
on the metabolic and physiologic differ-
ences between animals and humans, poten-
tially eliminating the need for uncertainty
factors. They can also be used for low-dose
extrapolation. By utilizing validated and
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sensitive exposure and effect biomarkers
that show strong correlation with tumor
development, it is possible to characterize
dose-response relationships at response
rates orders ofmagnitude lower and over a
much greater dose range than is currently
possible. Finally, incorporating exposure
and effect biomarkers in the characteriza-
tion ofinterindividual variability will allow
protection ofvulnerable individuals (39),
while avoiding the need to use uncertainty
factors to account for this variability. The
use of biomarkers in all four steps of risk
assessment is recommended.
e) Incorporate the use ofbiomarkers
in clinical settings and develop protocolsfor
collection ofspecimens.
Despite the importance of exposure
assessment epidemiologic studies, exposure
data is not developed at clinical centers as
part of a primary health evaluation or at
cancer childhood centers when new cases
appear. Although a few epidemiologic
studies have been conducted on children
living near toxic dump sites, application of
biomarkers to detect environmental toxic
exposures in the clinical setting has been
primarily used for lead poisoning and pas-
sive exposure to environmental tobacco
smoke. The use ofbiomarkers in a clinical
setting could facilitate the diagnosis ofcon-
ditions in children that occur as a result of
exposure to specific toxic substances. The
identification of a specific biomarker
should help to confirm that a child has
been exposed to a particular toxin and may
provide a tool to monitor either the effects
of the toxin or the effects of therapy. For
biomarkers to be used in a clinical setting,
methods to collect samples will need to be
appropriate to the child's age. Methods
for intrauterine analysis oftoxic exposures
are also needed. New, less invasive, and
painless methods for collecting biologic
materials from children are needed.
Exposure Assessment
The National Research Council report
Pesticides in the Diets ofInfants and
Children (9) found that infants and chil-
dren differ from adults in their exposures
and susceptibilities, both qualitatively and
quantitatively. The report indicated that
children's exposure to pesticides are greater
than those ofadults because they eat more
food, drink more water, and breathe more
air per unit ofbody weight than adults do.
For instance, the air intake of a resting
infant is twice that of an adult under the
same conditions. Infants and children
drink more than 2.5 times as much water
daily as adults do, relative to body weight
(42). During the first 6 months of life,
children drink 7 times as much water per
pound, and between the ages 1 through 5
years eat 3 to 4 times more food per pound
than the average American adult (9). In
addition, their activity patterns and loca-
tion further magnify exposure to pollu-
tants. Hand-to-mouth behavior increases
their ingestion oftoxins in dust or soil and
because they play close to the ground, they
are exposed to toxins that form low-lying
layers in the air, such as certain pesticide
vapors, radon, and particulate matter.
f) Develop a national databasefor
exposure data.
A national IRIS-type (U.S. EPA's
Integrated Risk Information System) data-
base for exposure data is needed to compile
chemical-specific exposure information.
This database would include environmen-
tal fate and transport information on the
chemical, information on its potential for
bioaccumulation, and critical pathways
that would result in exposure to children.
g) Define and characterize the child's
environmentbystudyingexposurepatterns.
To understand children's exposures, it is
first necessary to define their environment
and then link children's environment to
their behaviors. Children's micro- and
macroenvironments are different from
adults and change through development.
The time spent at home, daycare, or school
will result in completely different exposure
scenarios. In addition, children's environ-
ments may vary demographically and across
cultural groups. For example, children in
different cultures experience avariety ofdif-
ferent foods and lifestyle exposures. Thus,
exposure research efforts should be dedi-
cated to studying how children's character-
istic environments differ from adults, what
contaminants are found in their environ-
ment, and how their environment changes
with age, gender, and culture background.
Studies of children's activity patterns
are an essential component of estimating
their exposures, and research efforts should
be dedicated to this task. We need to
know more about the activities that chil-
dren engage in, and how to quantify
exposures arising from children's activi-
ties. For example, how often does a child
bring a toy to his/her mouth that has
touched a contaminated surface? What is
the distribution of ingestion rates of soil
and dust among children in various age
ranges? Little information is available on
the exposures derived from dermal contact,
ingestion, and inhalation ofpollutants on
floors, in household dust, and in the small
child's indoor breathing zone. Research on
activity patterns would include studies of
behavior and activities for evaluating the
duration, frequency, and extent of expo-
sure, dietary intakes, physiologic parame-
ters, and other relevant factors. Participants
suggested that an interdisciplinary team be
formed to research children's activities,
behavioral development periods, environ-
ments, and exposures. This team would
identify applicable categories for children
by behavior, age, functionality and biology,
and determine the average and range of
variance in behaviors among children
within agreed-upon groups. Cross-cultural
differences in dietary patterns through
development should also be studied.
h) Evaluate exposures to thefetus during
gestation.
Maternal preconception exposure to a
potential carcinogen may result in fetal
exposure to the parent chemical or to any
of the toxic metabolites produced by the
mother. In addition, the metabolic capac-
ity of the placenta may contribute to the
bioactivation or detoxification ofchemi-
cals. Research is recommended to study the
role ofthe placenta in protecting the fetus
from carcinogenic compounds and to eval-
uate the contribution of the metabolic
capacity ofthe placenta to fetal exposures.
i) Evaluate the contribution ofpaternal
exposures to children's exposures.
Children's exposures through the father
must also be studied. Exposure to pesticides
in children of farmers occurs when pesti-
cides are carried by the parents from the
field into the home. Buckley et al. (43)
found an association with acute lym-
phoblastic leukemia when both mother and
father had been exposed to pesticides. The
father's exposures may also contribute to
the genetic syndromes that result in cancer,
such as certain forms ofretinoblastoma or
Wilms tumor (22). Animal studies suggest
that paternal exposures to rats can affect
subsequent cancer risk without altering fer-
tility (44). Thus, more information is
needed on the role ofpaternal exposure in
childhood cancer.
j) Characterize exposures that occur
duringcriticalperiods ofdevelopment.
Special attention should be given to
exposures during specific periods ofdevel-
opment during which susceptibility to
cancer may be enhanced. For example, if
contraceptives are used during adolescence,
their contribution to outcomes such as
breast cancer may be different than what is
expected from adult users. For some types
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ofcancer, exposures at critical periods of
development, such as when a tissue or sys-
tem is rapidly developing, may greatly
increase the child's susceptibility to cancer.
k)Determine whether the techniques
currently used to measure contaminant con-
centration andcollect environmentalsamples
that are representative ofa child's exposure.
Develop protocolsfor environmentalsam-
pling that take into account the characteris-
tics ofthechild'senvironment.
Environmental data is often the only
available information to estimate exposures.
It is necessary to determine whether the
techniques currently used to measure con-
taminant concentrations andcollect environ-
mental samples are representative ofa child's
exposure. For example, air-monitoring
measurements are currently taken at adult
heights. These measurements may not be
representative ofthe air quality closer to the
ground, where children breathe. Thus,
environmental sampling should take into
consideration the specific characteristics of
children's environments.
1) Identifj highlyexposedpopulations.
It is also recommended that research is
done to target populations ofchildren who
are suspected to be more highly exposed
(e.g., children ofmigrant farm workers).
Collecting information from these research
studies may help to identify some exposure
factors from other chemicals. Information
from unique cancer clusters (e.g., DES)
could be better utilized to determine some
children's exposure factors.
Summary
Preventable causes of childhood cancer
were the focus of the conference. This is
an area in which we still have much to
learn. We do not yet know what fraction
of childhood cancers are due to pre-
ventable causes. We are only beginning-
on the basis of imperfect knowledge-to
develop strategies for prevention. The rec-
ommendations that were made at this
conference and that are summarized in
this report are intended to provide a blue-
print for closing gaps in knowledge and
thus for guiding prevention ofchildhood
cancer. We aim for future progress in pre-
vention equal to the progress in treatment
ofchildhood cancers.
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